YOLFTbeta
Physiomics Plc

Physiomics Plc

PYC · LSE · Healthcare / Biotechnology

0.425GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.425
Open0.425
Day Range0.40 – 0.4285
52-Week Range0.2525 – 0.80
Volume3.08M
Market Cap2.38M
P/E (TTM)0.00
Forward P/E6.17
EPS0.00
Dividend Yield0.00%
Beta1.03
50-Day Avg0.4995
200-Day Avg0.4843

About

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Ian Russell Bagnall
  • Employees10
  • HeadquartersMilton Park Innovation Centre, Oxford, United Kingdom, OX14 4RY, UK
  • Websitehttps://www.physiomics.co.uk

Leadership

  • Mr. Ian Russell BagnallCompany Secretary, Finance Director & Non-Executive Director · b. 1965
  • Mr. Jesse ThissenCOO & Head of Biometrics
  • Ms. Hayley CloseHead of Business Development
  • Dr. Venkata PutchaHead of Biostatistics
  • Mr. Michael David WhitlowExecutive Director · b. 1979

Financials

Income Statement

Currency: GBP2001-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Revenue-50.00K62.00K205.00K113.00K216.00K91.00K460.00K153.00K53.00K135.31K240.00K267.90K235.49K297.12K270.46K512.90K783.10K799.05K702.31K830.27K597.35K543.25K784.00K
Growth (%)--+24.00%+230.65%-44.88%+91.15%-57.87%+405.49%-66.74%-65.36%+155.29%+77.38%+11.63%-12.10%+26.17%-8.97%+89.64%+52.68%+2.04%-12.11%+18.22%-28.05%-9.06%+44.32%
Cost of Revenue-----------776.52K733.17K630.82K705.73K759.65K770.14K961.77K976.20K1.07M1.26M1.18M1.22M1.27M
Gross Profit-50.00K62.00K205.00K113.00K216.00K91.00K460.00K153.00K53.00K135.31K-536.52K-465.26K-395.33K-408.61K-489.19K-257.24K-178.67K-177.15K-365.79K-429.01K-581.62K-677.43K-435.08K
Gross Margin-100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-223.55%-173.67%-167.88%-137.52%-180.87%-50.15%-22.82%-22.17%-52.08%-51.67%-97.37%-124.70%-55.49%
Operating Expense-317.00K292.00K645.00K599.00K468.00K526.00K451.00K546.00K747.00K713.23K11.82K019.43K003.15K22.83K2-28.75K-69.89K-7.89K-6.61K22.71K
Operating Income-137.00K-267.00K-230.00K-440.00K-486.00K-252.00K-435.00K9.00K-393.00K-694.00K-577.92K-548.34K-465.26K-414.75K-408.61K-489.19K-260.39K-201.50K-177.15K-337.04K-359.11K-573.73K-670.82K-457.79K
Operating Margin--534.00%-370.97%-214.63%-430.09%-116.67%-478.02%1.96%-256.86%-1309.43%-427.12%-228.48%-173.67%-176.13%-137.52%-180.87%-50.77%-25.73%-22.17%-47.99%-43.25%-96.05%-123.48%-58.39%
EBITDA-127.00K-257.00K-222.00K-432.00K-469.00K-238.00K-424.00K16.00K-381.35K-687.46K-564.38K-535.25K-456.33K-407.83K-424.99K-525.49K-257.21K-192.82K-124.71K-324.52K-347.84K-561.57K-659.80K-448.21K
EBITDA Margin--514.00%-358.06%-210.73%-415.04%-110.19%-465.93%3.48%-249.25%-1297.10%-417.12%-223.02%-170.33%-173.19%-143.04%-194.29%-50.15%-24.62%-15.61%-46.21%-41.90%-94.01%-121.46%-57.17%
Net Income-142.00K-259.00K-225.00K-382.00K-480.00K-193.00K-434.00K25.00K-368.00K-645.00K-539.58K-500.57K-425.62K-357.66K-378.70K-400.53K-183.34K-104.04K-64.42K-215.83K-253.14K-477.26K-609.35K-415.25K
Net Income Margin--518.00%-362.90%-186.34%-424.78%-89.35%-476.92%5.43%-240.52%-1216.98%-398.78%-208.57%-158.87%-151.88%-127.46%-148.09%-35.75%-13.29%-8.06%-30.73%-30.49%-79.90%-112.17%-52.97%
R&D53.00K58.00K7.00K30.00K5.00K131.00K111.00K73.00K159.00K258.00K-186.49K259.92K168.12K165.52K211.22K--------
R&D as % of Total Revenue-116.00%11.29%14.63%4.42%60.65%121.98%15.87%103.92%486.79%-77.70%97.02%71.39%55.71%78.10%--------
Interest Expense0008.00K009.00K4.00K3.00K8.00K5.67K000804106791101420330
Interest Expense % of Total Revenue-0.00%0.00%3.90%0.00%0.00%9.89%0.87%1.96%15.09%4.19%0.00%0.00%0.00%0.00%0.00%0.01%0.00%0.08%0.02%0.02%0.00%0.01%0.00%

Balance Sheet

Currency: GBP2001-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets139.00K79.00K93.00K527.00K146.00K303.00K114.00K275.00K922.00K868.00K840.10K380.47K244.19K378.87K303.31K415.18K818.23K694.29K1.45M1.32M1.12M674.39K422.60K892.03K
Total Liabilities9.00K208.00K447.00K114.00K212.00K204.00K468.00K360.00K135.00K112.00K105.53K124.64K107.71K53.25K99.16K86.92K128.21K86.37K131.52K157.57K140.61K142.67K140.08K199.85K
Total Equity130.00K-129.00K-354.00K413.00K-66.00K99.00K-353.70K-85.00K787.00K756.00K734.57K255.82K136.49K325.62K204.15K328.25K690.03K607.91K1.31M1.17M974.81K531.72K282.53K692.17K
Cash48.00K3.00K8.00K295.00K26.00K75.00K9.00K95.00K780.00K730.00K690.95K179.16K132.36K266.75K138.91K209.75K571.87K405.37K1.05M1.04M687.67K416.59K191.07K461.24K
Total Debt--405.00K--82.00K8.00K63.00K-------------7.35K3.83K-
Net Debt-48.00K-3.00K397.00K-295.00K-26.00K7.00K-1.00K-32.00K-780.00K-730.00K-690.95K-179.16K-132.36K-266.75K-138.91K-209.75K-571.87K-405.37K-1.05M-1.04M-687.67K-416.59K-191.07K-461.24K

Cash Flow

Currency: GBP2001-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Operating Cash Flow-153.00K-203.00K-218.00K-428.00K-273.00K-387.00K-123.00K26.00K-434.00K-643.00K-551.77K-524.49K-351.51K-392.65K-346.87K-437.27K-169.80K-143.77K-115.69K-32.50K-349.25K-264.86K-548.13K-546.14K
Investing Cash Flow-71.00K-11.00K-12.00K-10.00K4.00K-4.00K-1.00K-1.00K4.00K1.00K3.77K2.70K-1.58K-321-967-6.65K-2.29K-22.73K-5.09K-16.15K-9.37K-6.22K-15.21K-3.41K
Financing Cash Flow272.00K169.00K235.00K724.00K-439.00K58.00K61.00K1.11M592.00K509.34K10.00K306.29K527.36K220.00K514.76K534.21K763.28K763.28K44.24K2.85K-337.83K819.73K
Capital Expenditure66.00K11.00K12.00K18.00K2.00K4.00K1.00K1.00K1.00K7.00K1.91K1.85K2.60K6251.83K6.80K2.33K21.82K5.09K16.15K9.37K6.63K17.31K3.94K
Free Cash Flow-219.00K-214.00K-230.00K-446.00K-275.00K-391.00K-124.00K25.00K-435.00K-650.00K-553.68K-526.34K-354.10K-393.28K-348.70K-444.08K-172.12K-165.59K-120.78K-48.65K-358.62K-271.50K-565.44K-550.08K
FCF to OCF143.14%105.42%105.50%104.21%100.73%101.03%100.81%96.15%100.23%101.09%100.35%100.35%100.74%100.16%100.53%101.56%101.37%115.17%104.40%149.71%102.68%102.51%103.16%100.72%

Key Statistics & Ratios

Market Cap2.38M
Enterprise Value2.12M
Trailing P/E0.00
Forward P/E6.17
PEG Ratio0.00
Price / Sales2.36
Price / Book6.05
EPS0.00
Book Value0.001
Revenue (TTM)1.01M
Gross Profit (TTM)-513.08K
EBITDA-523.33K
Profit Margin-48.13%
Operating Margin-61.93%
Return on Equity-119.67%
Return on Assets-61.62%
Shares Outstanding453.21M
Shares Float203.54M
Beta1.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Dec 19, 20161:100